Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life

NCT04050592 · clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
150
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Hanna Savolainen-Peltonen

Collaborators